Population pharmacokinetic model development and its relationship with adverse events of oxcarbazepine in adult patients with epilepsy.

Sci Rep · 2021 · PMC7973549 · PMID 33737678

Europe PMC DOI

hedged sentence

0.0530

closest p · 1.1× alpha

0.0530

boldest claim

The sentences

did not reach statistical significancep = 0.053so close (0.05 < p ≤ 0.1)

The OXC dose was also higher in the patients who showed only dizziness, but it did not reach statistical significance (1216 vs. 989, p = 0.053).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.